Safety and disease response to MEDI-551, an anti-CD19 antibody, in chronic lymphocytic leukemia patients previously treated with rituximab. (7th November 2013)
- Record Type:
- Journal Article
- Title:
- Safety and disease response to MEDI-551, an anti-CD19 antibody, in chronic lymphocytic leukemia patients previously treated with rituximab. (7th November 2013)
- Main Title:
- Safety and disease response to MEDI-551, an anti-CD19 antibody, in chronic lymphocytic leukemia patients previously treated with rituximab
- Authors:
- Forero, Andres
Hamadani, Mehdi
Kipps, Thomas
Fanale, Michelle
Cuneo, Antonio
Perez de Oteyza, Jaime
Gladstone, Douglas
Andre, Marc
Bellam, Naresh
Goswami, Trishna
Ibrahim, Ramy
Schneider, Amy
Liang, Meina
Eck, Steven
Elgeioushi, Nairouz
Herbst, Ronald
Cheson, Bruce D - Abstract:
- Is Part Of:
- Journal for immunotherapy of cancer. Volume 1(2013)Supplement 1
- Journal:
- Journal for immunotherapy of cancer
- Issue:
- Volume 1(2013)Supplement 1
- Issue Display:
- Volume 1, Issue 1 (2013)
- Year:
- 2013
- Volume:
- 1
- Issue:
- 1
- Issue Sort Value:
- 2013-0001-0001-0000
- Page Start:
- Page End:
- Publication Date:
- 2013-11-07
- Subjects:
- Chronic Lymphocytic Leukemia -- Bendamustine -- Chronic Lymphocytic Leukemia Patient -- BAFF Level -- Receive Study Drug
Cancer -- Immunotherapy -- Periodicals
Cancer -- Immunological aspects -- Periodicals
Tumors -- Immunological aspects -- Periodicals
Immunotherapy -- Periodicals
616.99406105 - Journal URLs:
- http://www.immunotherapyofcancer.org ↗
https://jitc.bmj.com/ ↗
http://link.springer.com/ ↗ - DOI:
- 10.1186/2051-1426-1-S1-P43 ↗
- Languages:
- English
- ISSNs:
- 2051-1426
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19215.xml